Osaka, Japan

Tammam Alama

This inventor holds 1 USPTO granted patent, plus 1 CIPO patent. Top assignees: Rohto Pharmaceutical Co., Ltd., The Mentholatum Company. Active years: 2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Tammam Alama. Retrieved from https://idiyas.com/inventor/tammam-alama

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0


Average Co-Inventor Count = 2.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Tammam Alama: Innovator in Topical Compositions

Introduction

Tammam Alama is a notable inventor based in Osaka, Japan. He has made significant contributions to the field of topical compositions, particularly in enhancing the permeability of active ingredients through the skin barrier. His innovative approach addresses critical challenges in dermatological formulations.

Latest Patents

Tammam Alama holds a patent for a topical composition aimed at providing excellent permeability in the stratum corneum. The patent includes a formulation that comprises one or more antifungal agents, such as tolnaftate, and a selection of compounds that enhance the delivery of these agents. This innovative composition is designed to improve the effectiveness of antifungal treatments.

Career Highlights

Throughout his career, Tammam Alama has worked with reputable companies, including The Mentholatum Company and Rohto Pharmaceutical Co., Ltd. His experience in these organizations has allowed him to develop and refine his expertise in pharmaceutical formulations.

Collaborations

Tammam has collaborated with various professionals in the industry, including Yoshiaki Kawaguchi, who has contributed to his research and development efforts.

Conclusion

Tammam Alama's work in developing topical compositions showcases his commitment to innovation in the pharmaceutical field. His contributions are paving the way for more effective treatments in dermatology.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…